SCHEMBL24368147

SCHEMBL24368147

CC(C)c1cccc(C(=O)Nc2ccc3ncccc3c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.69
NPC1 O15118 7/20 0.69
RAB9A P51151 6/20 0.69
CASP3 P42574 1/20 0.69
SENP8 Q96LD8 1/20 0.69
SENP7 Q9BQF6 1/20 0.69
SENP6 Q9GZR1 1/20 0.69
POLB P06746 2/20 0.65
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 1/20 0.58
BRAF P15056 3/20 0.56
ALDH1A1 P00352 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
PLK1 P53350 1/20 0.52
HTT P42858 1/20 0.52
CSF1R P07333 1/20 0.52
KDR P35968 4/20 0.52
TEK Q02763 4/20 0.52
CRHBP P24387 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13702131 0.85 RAB9A (0.64) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL19663015 0.84 NPC1 (0.77) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL29429748 0.82 PABPC1 (1.00) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL6978685 0.82 PABPC1 (1.00) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL30503659 0.81 PABPC1 (0.74) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL19663016 0.81 PABPC1 (0.74) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL29024922 0.81 PABPC1 (0.74) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL21237369 0.81 PABPC1 (0.69) PABPC1NPC1RAB9ACASP3SENP8
SCHEMBL23844177 0.79 FADS1 (0.62) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL13863923 0.78 MEN1 (0.71) PABPC1NPC1RAB9ACASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127265-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127265-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF EP300, HDAC1, CREBBP PABPC1 3748/4885NPC1 387/4885RAB9A 3405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.